280 related articles for article (PubMed ID: 24878851)
21. A20: attractive without showing cleavage.
Verhelst K; van Loo G; Beyaert R
EMBO Rep; 2014 Jul; 15(7):734-5. PubMed ID: 24878850
[TBL] [Abstract][Full Text] [Related]
22. Elucidating dynamic protein-protein interactions and ubiquitination in NF-κB signaling pathways.
Shembade N; Harhaj EW
Methods Mol Biol; 2015; 1280():283-95. PubMed ID: 25736755
[TBL] [Abstract][Full Text] [Related]
23. Dimerization and ubiquitin mediated recruitment of A20, a complex deubiquitinating enzyme.
Lu TT; Onizawa M; Hammer GE; Turer EE; Yin Q; Damko E; Agelidis A; Shifrin N; Advincula R; Barrera J; Malynn BA; Wu H; Ma A
Immunity; 2013 May; 38(5):896-905. PubMed ID: 23602765
[TBL] [Abstract][Full Text] [Related]
24. Regulation of NF-κB signaling by the A20 deubiquitinase.
Shembade N; Harhaj EW
Cell Mol Immunol; 2012 Mar; 9(2):123-30. PubMed ID: 22343828
[TBL] [Abstract][Full Text] [Related]
25. A20 restricts ubiquitination of pro-interleukin-1β protein complexes and suppresses NLRP3 inflammasome activity.
Duong BH; Onizawa M; Oses-Prieto JA; Advincula R; Burlingame A; Malynn BA; Ma A
Immunity; 2015 Jan; 42(1):55-67. PubMed ID: 25607459
[TBL] [Abstract][Full Text] [Related]
26. The zinc finger protein A20 inhibits TNF-induced NF-kappaB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-kappaB-inhibiting protein ABIN.
Heyninck K; De Valck D; Vanden Berghe W; Van Criekinge W; Contreras R; Fiers W; Haegeman G; Beyaert R
J Cell Biol; 1999 Jun; 145(7):1471-82. PubMed ID: 10385526
[TBL] [Abstract][Full Text] [Related]
27. Spontaneous NF-κB activation by autocrine TNFα signaling: a computational analysis.
Pękalski J; Zuk PJ; Kochańczyk M; Junkin M; Kellogg R; Tay S; Lipniacki T
PLoS One; 2013; 8(11):e78887. PubMed ID: 24324544
[TBL] [Abstract][Full Text] [Related]
28. Frequent inactivation of A20 in B-cell lymphomas.
Kato M; Sanada M; Kato I; Sato Y; Takita J; Takeuchi K; Niwa A; Chen Y; Nakazaki K; Nomoto J; Asakura Y; Muto S; Tamura A; Iio M; Akatsuka Y; Hayashi Y; Mori H; Igarashi T; Kurokawa M; Chiba S; Mori S; Ishikawa Y; Okamoto K; Tobinai K; Nakagama H; Nakahata T; Yoshino T; Kobayashi Y; Ogawa S
Nature; 2009 Jun; 459(7247):712-6. PubMed ID: 19412163
[TBL] [Abstract][Full Text] [Related]
29. ABINs: A20 binding inhibitors of NF-kappa B and apoptosis signaling.
Verstrepen L; Carpentier I; Verhelst K; Beyaert R
Biochem Pharmacol; 2009 Jul; 78(2):105-14. PubMed ID: 19464428
[TBL] [Abstract][Full Text] [Related]
30. A20 expression in dendritic cells protects mice from LPS-induced mortality.
Xuan NT; Wang X; Nishanth G; Waisman A; Borucki K; Isermann B; Naumann M; Deckert M; Schlüter D
Eur J Immunol; 2015 Mar; 45(3):818-28. PubMed ID: 25472594
[TBL] [Abstract][Full Text] [Related]
31. A20 and CYLD do not share significant overlapping functions during B cell development and activation.
Chu Y; Soberon V; Glockner L; Beyaert R; Massoumi R; van Loo G; Krappmann D; Schmidt-Supprian M
J Immunol; 2012 Nov; 189(9):4437-43. PubMed ID: 23002441
[TBL] [Abstract][Full Text] [Related]
32. A20 inhibits LUBAC-mediated NF-κB activation by binding linear polyubiquitin chains via its zinc finger 7.
Verhelst K; Carpentier I; Kreike M; Meloni L; Verstrepen L; Kensche T; Dikic I; Beyaert R
EMBO J; 2012 Oct; 31(19):3845-55. PubMed ID: 23032186
[TBL] [Abstract][Full Text] [Related]
33. Enterocyte-specific A20 deficiency sensitizes to tumor necrosis factor-induced toxicity and experimental colitis.
Vereecke L; Sze M; Mc Guire C; Rogiers B; Chu Y; Schmidt-Supprian M; Pasparakis M; Beyaert R; van Loo G
J Exp Med; 2010 Jul; 207(7):1513-23. PubMed ID: 20530205
[TBL] [Abstract][Full Text] [Related]
34. Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease.
Zhou Q; Wang H; Schwartz DM; Stoffels M; Park YH; Zhang Y; Yang D; Demirkaya E; Takeuchi M; Tsai WL; Lyons JJ; Yu X; Ouyang C; Chen C; Chin DT; Zaal K; Chandrasekharappa SC; Hanson EP; Yu Z; Mullikin JC; Hasni SA; Wertz IE; Ombrello AK; Stone DL; Hoffmann P; Jones A; Barham BK; Leavis HL; van Royen-Kerkof A; Sibley C; Batu ED; Gül A; Siegel RM; Boehm M; Milner JD; Ozen S; Gadina M; Chae J; Laxer RM; Kastner DL; Aksentijevich I
Nat Genet; 2016 Jan; 48(1):67-73. PubMed ID: 26642243
[TBL] [Abstract][Full Text] [Related]
35. Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice.
Lee EG; Boone DL; Chai S; Libby SL; Chien M; Lodolce JP; Ma A
Science; 2000 Sep; 289(5488):2350-4. PubMed ID: 11009421
[TBL] [Abstract][Full Text] [Related]
36. Vitamin E γ-Tocotrienol Inhibits Cytokine-Stimulated NF-κB Activation by Induction of Anti-Inflammatory A20 via Stress Adaptive Response Due to Modulation of Sphingolipids.
Wang Y; Park NY; Jang Y; Ma A; Jiang Q
J Immunol; 2015 Jul; 195(1):126-33. PubMed ID: 26002975
[TBL] [Abstract][Full Text] [Related]
37. Aggravation of post-ischemic liver injury by overexpression of A20, an NF-κB suppressor.
Yu J; Lee HS; Lee SM; Yu HC; Moon WS; Chung MJ; Park JW; Park BH
J Hepatol; 2011 Aug; 55(2):328-36. PubMed ID: 21167234
[TBL] [Abstract][Full Text] [Related]
38. MiR-221 activates the NF-κB pathway by targeting A20.
Zhao D; Zhuang N; Ding Y; Kang Y; Shi L
Biochem Biophys Res Commun; 2016 Mar; 472(1):11-8. PubMed ID: 26549234
[TBL] [Abstract][Full Text] [Related]
39. The RING ubiquitin E3 RNF114 interacts with A20 and modulates NF-κB activity and T-cell activation.
Rodriguez MS; Egaña I; Lopitz-Otsoa F; Aillet F; Lopez-Mato MP; Dorronsoro A; Lobato-Gil S; Sutherland JD; Barrio R; Trigueros C; Lang V
Cell Death Dis; 2014 Aug; 5(8):e1399. PubMed ID: 25165885
[TBL] [Abstract][Full Text] [Related]
40. The biology of A20-binding inhibitors of NF-kappaB activation (ABINs).
Verstrepen L; Carpentier I; Beyaert R
Adv Exp Med Biol; 2014; 809():13-31. PubMed ID: 25302363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
